---
title: Targeting A2M-LRP1 reverses uterine spiral artery remodeling disorder and alleviates
  the progression of preeclampsia
date: '2025-02-25'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39994728/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20250225171113&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSION: SMC A2M promotes the progression of preeclampsia by directly
  upregulating RhoA-GTPase. Our findings also reveal that A2M serve as a potential
  target for EOPE and provide a preliminary therapy for inhibit the combination of
  ...'
disable_comments: true
---
CONCLUSION: SMC A2M promotes the progression of preeclampsia by directly upregulating RhoA-GTPase. Our findings also reveal that A2M serve as a potential target for EOPE and provide a preliminary therapy for inhibit the combination of ...